These press releases are intended for business journalists and analysts/investors
GSK Australia is proud to be partnering with the Australian Government to provide a quadrivalent (four-strain) influenza vaccine for the National Immunisation Program (NIP) for the 2016 season.
Dr Ginni Mansberg ambassador for ‘Tried-It-All’ hay fever campaign launched today
Read more - GSK and Sun Pharma complete Opiates transaction Read more
Read more - GSK's parting gifts to local community Read more
Recall of five batches of Bactroban Cream and three batches of Bactroban Nasal Ointment
WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria
Zovirax Ophthalmic Ointment (aciclovir 3%) is impacted by an ongoing global supply constraint with no confirmed resupply date in Australia.
Read more - Update on supply of Zovirax Ophthalmic Ointment (aciclovir 3%) Read more
Australian campaign focuses on enlarged prostates
GSK Australia and New Zealand have published the third annual responsible business report, outlining key achievements in health, community and environmental sustainability.
Read more - GSK Australia releases 2014 Responsible Business Report Read more
GSK Australia has a new immunisation resource for Aboriginal and Torres Strait Islanders this month to encourage families to be proactive when it comes to immunising themselves and their children against preventable diseases.